April 1st’s Lesson 🎭 Fool’s Gold or Deep Tech Jackpot?
The Tuesday Current (April 01, 2025): Where Risks Cash In, Trump's Tariffs Fool Who?
Happy April Fool’s Day! The wildest risks can outsmart the crowd, and we’re here to unpack 2025’s boldest moves in venture capital, where “foolish” ideas spark the next frontier. ThinkFISH drops these edges weekly—quiet wins to keep you ahead.
Let’s dive in.
🔥 What’s Breaking Now
Tariff Turbulence
Trump’s tariff threats sliced biopharma indices 8% in March—HSBC flags a $12B hit. Who’s laughing when the market shifts?China’s $138B Deep Tech Stack
A $138B state fund, with $27.6B for Deep tech—AI drugs and synthetic biology. Goldman projects a 15% CAGR through 2030. Fool’s gold or a lock?Isomorphic’s $600M AI Win
Google Ventures dropped $600M into Isomorphic Labs last week. Their AI cuts drug R&D cycles by 30%. Smart move, or hype train?
🔍 Opportunities at ThinkFISH
We don’t play it safe; we outsmart the odds. April Fool’s favors the gutsy—here’s who we’re backing to flip deep tech:
Tenon Ventures - Operator-led deep tech VC, building the future hands-on. A Boston-based venture fund crafting the next generation of deep tech companies in AI, optics, energy, robotics, and manufacturing—focused on Pre-Seed to Series A startups with defensible tech and market validation.
Why Investors Love It:
Team’s 7x exits—proven builders with a $2B+ track record (Pixtronix: 33x, Triib: 93x).
Deep tech’s 2x unicorn rate and 26% IRR—outpacing traditional VC.
LinkedIn Profile | Book an Intro Call | Investor Deck | One-Pager
Wave Function Ventures - Deep tech’s early-stage wave rider, atoms over bits. An LA-based venture fund investing in seed and pre-seed deep tech startups in aerospace, defense, energy, and robotics—focused on hardware-driven solutions with generational potential.
Why Investors Love It:
$1.25M deployed across 5 deals in 2024 — 2.5x MOIC via SAFE markups (Persona AI: 4.29x).
Founder Jamie Gull’s SpaceX and Y Combinator pedigree—20+ angel investments, 100% survival rate.
1435 Capital - BioFrontiers’ biotech trailblazer, redefining health span. A Princeton-based venture fund investing in Seed to Series A biotech startups, leveraging Earth and space-based innovations to combat age-related diseases with regenerative medicine, gene therapies, and microgravity biomanufacturing.
Why Investors Love It:
Taps a $5.7T biotech market by 2033—$1.8T Medicare demand by 2031.
Proprietary deal flow via NASA’s InSPA Program—focus on high-growth immunotherapies.
LinkedIn Profile | Book an Intro Call | Investor Deck | One-Pager
🔍 Under-the-Radar Movers
AI’s $40B OpenAI Blitz
OpenAI’s nearing a $40B round amid Ghibli Copyright firestorm—SoftBank’s in for $7.5B now, $22.5B later.M&A’s $54.5B Q1 Surge
Q1 2025 M&A hit $54.5B—deep tech’s in the mix. (Read More)Tech’s $325M Exit Pop
Braze scooped OfferFit for $325M—AI-driven exits are live.
💡 Your 2025 Edge
Why do bold bets sting? Deep tech’s long timelines grind LPs while AI races ahead. Tenon’s operator-led builders, 1435’s BioFrontiers healthspan mission, Wave’s hardware-driven innovators. The April fool’s edge? Smaller bets often outpace the hype. The Twist: What if 2025’s biggest wins come from the moves you’re not watching?
Watch Full YouTube Video [Here]
April Fool’s Day proves it: deep tech’s sharpest wins hide in the edges. Tenon, Wave and 1435 Capital are betting where others won’t—on AI-driven robotics, space-enabled biotech, and hardware breakthroughs. The next frontier isn’t loud—it’s early. Where’s your portfolio looking?
April 1st isn’t just for pranks—it’s a reminder to question what’s real and what’s just fool’s gold. A clever take on discernment in business and life!